A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies - Publication - Authors - KSSG Research Database

Publication

A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies

Journal Paper/Review - Nov 4, 2009

du Bois A, Huober Jens, Stopfer P, Pfisterer J, Wimberger P, Loibl S, Reichardt V L, Harter P

du Bois, A

Huober, Jens

chief physician
Brustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I

Stopfer, P

Pfisterer, J

Wimberger, P

Loibl, S

Reichardt, V L

Harter, P